Latest Insider Transactions at Century Therapeutics, Inc. (IPSC)
This section provides a real-time view of insider transactions for Century Therapeutics, Inc. (IPSC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Century Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Century Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2025
|
Chad Cowan Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
58,060
+5.26%
|
$0
$0.85 P/Share
|
|
Dec 12
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Open market or private purchase
|
Direct |
52,000
+1.54%
|
$0
$0.58 P/Share
|
|
Dec 10
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-0.01%
|
$0
$0.53 P/Share
|
|
Dec 08
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
257
-0.06%
|
$0
$0.53 P/Share
|
|
Dec 08
2025
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
526
-0.13%
|
$0
$0.53 P/Share
|
|
Nov 20
2025
|
Chad Cowan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,462
-0.55%
|
$0
$0.5 P/Share
|
|
Nov 19
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Open market or private purchase
|
Direct |
35,000
+1.06%
|
$0
$0.5 P/Share
|
|
Nov 17
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
32,456
-0.99%
|
$0
$0.45 P/Share
|
|
Nov 03
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
292
-0.07%
|
$0
$0.59 P/Share
|
|
Sep 18
2025
|
Chad Cowan Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
762,543
+43.45%
|
-
|
|
Sep 08
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
263
-0.06%
|
$0
$0.5 P/Share
|
|
Sep 08
2025
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
539
-0.14%
|
$0
$0.5 P/Share
|
|
Sep 08
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
488
-0.01%
|
$0
$0.5 P/Share
|
|
Aug 14
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,587,614
+32.69%
|
-
|
|
Aug 04
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
296
-0.07%
|
$0
$0.53 P/Share
|
|
Jun 09
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
475
-0.03%
|
$0
$0.62 P/Share
|
|
Jun 09
2025
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
552
-0.22%
|
$0
$0.62 P/Share
|
|
Jun 09
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
4,904
-1.19%
|
$0
$0.62 P/Share
|
|
Jun 09
2025
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
526
-0.13%
|
$0
$0.62 P/Share
|
|
May 16
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
29,552
-1.73%
|
$0
$0.55 P/Share
|
|
May 05
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
295
-0.07%
|
$0
$0.55 P/Share
|
|
May 05
2025
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,024
-0.41%
|
$0
$0.55 P/Share
|
|
Mar 11
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
521,500
+23.35%
|
-
|
|
Mar 11
2025
|
Chad Cowan Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+7.81%
|
-
|
|
Mar 11
2025
|
Morgan Conn Chief Finanical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+19.67%
|
-
|
|
Mar 11
2025
|
Douglas Carr SVP Finance & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
95,625
+18.87%
|
-
|
|
Mar 11
2025
|
Adrienne Farid Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+32.28%
|
-
|
|
Mar 11
2025
|
Gregory Russotti |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+23.41%
|
-
|
|
Mar 10
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
2,235
-0.19%
|
$0
$0.62 P/Share
|
|
Mar 10
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
1,240
-0.39%
|
$0
$0.62 P/Share
|
|
Mar 10
2025
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,359
-1.76%
|
$0
$0.62 P/Share
|
|
Mar 10
2025
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
2,360
-0.86%
|
$0
$0.62 P/Share
|
|
Feb 18
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
34,712
-2.83%
|
$0
$0.78 P/Share
|
|
Feb 03
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
351
-0.11%
|
$0
$0.78 P/Share
|
|
Feb 03
2025
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,054
-0.78%
|
$0
$0.78 P/Share
|
|
Dec 04
2024
|
Brent Pfeiffenberger President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
243,447
-16.55%
|
$243,447
$1.44 P/Share
|
|
Nov 04
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,033
-0.76%
|
$1,033
$1.23 P/Share
|
|
Nov 04
2024
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
283
-0.09%
|
$283
$1.23 P/Share
|
|
Nov 01
2024
|
Douglas Carr SVP Finance & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
16,611
-4.97%
|
$16,611
$1.26 P/Share
|
|
Oct 14
2024
|
Morgan Conn Chief Finanical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,148
+50.0%
|
-
|
|
Oct 01
2024
|
Chad Cowan Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,376
+26.08%
|
-
|
|
Sep 12
2024
|
Daphne Quimi Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$5,000
$1.53 P/Share
|
|
Aug 05
2024
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
289
-0.09%
|
$289
$1.83 P/Share
|
|
Aug 05
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,073
-0.78%
|
$1,073
$1.83 P/Share
|
|
Jul 26
2024
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
586
-0.21%
|
$1,172
$2.5 P/Share
|
|
Jul 24
2024
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
1,600
-0.58%
|
$3,200
$2.52 P/Share
|
|
Jul 23
2024
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
200
-0.07%
|
$400
$2.5 P/Share
|
|
Jun 20
2024
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
5,000
-1.77%
|
$10,000
$2.84 P/Share
|
|
Jun 07
2024
|
Douglas Carr SVP Finance & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
17,007
+4.84%
|
-
|
|
Jun 05
2024
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
5,000
-1.74%
|
$15,000
$3.0 P/Share
|